Jataizinho (BR) Cancer Clinical Trials

A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer

~16 mi. (Londrina, Brazil, +192 more cities)

Hospital de Cancer de Londrina

ER Positive, +1 more biomarker

Breast Carcinoma

abemaciclib, +1 more drug

hormone therapy, +1 more type

A Study of Selpercatinib (LY3527723) in Participants With Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer

~16 mi. (Londrina, Brazil, +184 more cities)

Hospital de Cancer de Londrina

RET Fusion

Non-Squamous Non-Small Cell Lung Carcinoma

selpercatinib

targeted therapy

A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer

~16 mi. (Londrina, Brazil, +143 more cities)

Hospital de Cancer de Londrina

RET Mutation

Thyroid Gland Medullary Carcinoma

selpercatinib

targeted therapy

A Study of Pembrolizumab (MK-3475) With or Without Lenvatinib (E7080/MK-7902) as First Line (1L) Intervention in a Programmed Cell Death-ligand 1 (PD-L1) Selected Population With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC) (LEAP-010) (MK-7902-010)

~83 mi. (Maringá, Brazil, +127 more cities)

ELO Pesquisa Clinica ( Site 0405)

Hypopharyngeal Squamous Cell Carcinoma, +3 more conditions

lenvatinib, +1 more drug

immunotherapy, +1 more type